Intrinsic Value

Cytek Biosciences, Inc. (CTKB)


-0.22 (-1.84%)

Enterprise Value -10,998.63
Net Debt -364.62
Equity Value -10,634.01
Shares Outstanding 81.54
Equity Value Per Share -130.41

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt